GHRP-6
Also known as: Growth Hormone Releasing Peptide-6
First synthetic GHRP with strong appetite-stimulating effects alongside GH release.
Evidence
Moderate
FDA status
Not FDA-approved
Source
Synthetic hexapeptide ghrelin mimetic
Overview
First synthetic GHRP with strong appetite-stimulating effects alongside GH release.
Mechanism of Action
Activates ghrelin receptor (GHS-R1a) for GH secretion, appetite stimulation via ghrelin pathway, moderate cortisol and prolactin increase, studied alongside GHRH.
What research has looked at
Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.
- GH and IGF-1 elevation
- Appetite
- Muscle growth support
- Enhanced recovery
- Improved sleep
- Anti-inflammatory effects
Researched for
Research topics, not approved uses.
How Gabriel approaches peptides
Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. GHRP-6 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.
Research & Evidence
Clinical trials, extensive research as first GHRP
Well-characterized GH secretagogue. Clinical evidence for GH elevation. Strongest appetite effects of GHRP family. Long-term safety data are lacking.
Safety Information
Potential Side Effects
- •Significant increased hunger
- •Water retention
- •Numbness/tingling
- •Cortisol and prolactin elevation
Contraindications
- Active cancer
- Pregnancy
- Breastfeeding
Interactions
- ⚠Synergistic with GHRH analogs
Quick Facts
Related Peptides
CJC-1295
Long-acting GHRH analog that stimulates sustained growth hormone release.
Ipamorelin
Selective ghrelin mimetic that triggers rapid growth hormone release without affecting cortisol or prolactin.
Tesamorelin
Synthetic GHRH analog FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy.